Deep Pharma Intelligence

New Era in Pharma Analytics

Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries.  DPI is producing regular analytical reports on major areas of high-potential in the pharmaceutical and healthcare industries, maintaining ratings of companies and governments based on their innovation potential and business activity in the BioTech space, and providing strategic consulting and investment intelligence services to top-tier clients. 

New Era in Pharma Analytics

AI in Drug Discovery:
Focus on Oncology Q3 2021
AI in Drug Discovery:
Focus on Oncology Q2 2021
(Teaser)-AI-in-Drug-Discovery-Focus-on-Oncology-Q3-2021 (1).png
Artificial Intelligence in Pharma Q2 2021
Artificial Intelligence in Pharma 2020
SPACs in Healthcare Q3 2021
Advanced Technologies in Pharma Q2 2021
AI in Drug Discovery:
Focus on Oncology Q2 2021
AI in Drug Discovery:
Focus on Oncology Q2 2021
onco.JPG
AI in Drug Discovery:
Focus on Oncology Q1 2021
Cell Therapies in Healthcare Q2 2021
Global Investment Digest
Advanced Visualisation Prototypes
Asia Investment Digest
 
5 High-Impact Technology Companies
Pharmaceutical Artificial Intelligence Deals And Market 2020-2021